Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study-Reference-Cited by-同舟云学术

Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study

Published:2018-06-26 Issue:4 Volume:4 Page:220-227
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Sindet-Pedersen Caroline¹²³,Staerk Laila¹²,Pallisgaard Jannik Langtved¹,Gerds Thomas Alexander⁴⁵,Berger Jeffrey S³,Torp-Pedersen Christian¹⁶,Gislason Gunnar H¹²⁴⁷,Olesen Jonas Bjerring¹

Affiliation:

1. Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Kildegaardsvej 28, Hellerup, Denmark

2. Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, Copenhagen N, Denmark

3. Department of Medicine, New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY, USA

4. The Danish Heart Foundation, Vognmager gade 7, Copenhagen K, Copenhagen, Denmark

5. Department of Public Health, Section of Biostatistics, University of Copenhagen, Øster Farimagsgade 5, Copenhagen K, Denmark

6. Department of Health Science and Technology, Public Health and Epidemiology Group, Aalborg University Hospital, Niels Jernes Vej 12, Aalborg Ø, Denmark

7. Department of Public Health, University of Southern Denmark, J.B. Winsløws Vej 9B, Odense C, Denmark

Funder

The Danish Counsel of Independent Research

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/article-pdf/4/4/220/25719583/pvy021.pdf

Reference26 articles.

1. Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism—a Danish nationwide cohort study;Sindet-Pedersen;Sci Rep,2017

2. Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments;Mega;Lancet,2015